Skip to content

Comparison of the effect of ketamine-propofol combination with ketamine-thiopental in improving depressive symptoms in patients undergoing electroconvulsive therapy

The Comparison of the effect of combining Ketamine-Propofol and Ketamine- Thiopental during Electroconvulsive Therapy in Reducing the Symptoms in Patients with Major Depression Disorder :a clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211009052708N1
Enrollment
60
Registered
2021-10-28
Start date
2021-10-23
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression. Mood disorder due to known physiological condition with major depressive-like episode

Interventions

Intervention 1: Intervention group: Combination of thiopental at a dose of 3 mg / kg with ketamine at a dose of 0.5 mg / kg after administration of 0.5 mg atropine at the beginning of ECT. Interventio

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Includes: Diagnosis of moderate to severe depression episode affected by DSM-5 age at least 18 years performance and willingness to provide written consent by patient or legal guardian verbal IQ of 8.5 or greater undergoing ECT treatment in the past six months To be caught

Exclusion criteria

Exclusion criteria: Inability to provide informed written consent in the absence of a legal guardian primary psychotic or schizoaffective disorder obsessive-compulsive disorder concomitant diagnosis of multiple psychiatric disorders in axis one and two anorexia nervosa history of substance or alcohol dependence sensitivity to Anesthesia drugs or contraindications for their administration ECT in the last three months contraindications for ECT such as organic brain diseases and dementia major medical conditions that affect neuropsychological function pregnancy or lack of proper contraception breastfeeding Occurrence of psychotic symptoms or exacerbation of depressive symptoms during the study

Design outcomes

Primary

MeasureTime frame
Depression score in Beck questionnaire. Timepoint: Before the start of the first ECT session and at the end of the third and sixth sessions, the Beck Depression Inventory test is performed on all samples. Method of measurement: Beck Depression Inventory.

Secondary

MeasureTime frame
Quality of life score. Timepoint: After the end of the treatment period. Method of measurement: Short questionnaire SF-12.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAysan Taravati

Semnan University of Medical Sciences

dr.a.taravati@gmail.com+98 23 3344 1022

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026